From: Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle
Tissue/organa | EXPERIMENT #4 | |||
---|---|---|---|---|
15 h | 24 h | |||
Mean | SD | Mean | SD | |
Blood | 0.028 | 0.001 | 0.014 | 0.003 |
Tumour pos | 1.079 | 0.166 | 0.540 | 0.180 |
Tumour neg | 0.258 | 0.014 | 0.135 | 0.008 |
Lungs | 0.214 | 0.023 | 0.216 | 0.146 |
Liver | 0.017 | 0.004 | 0.012 | 0.005 |
Spleen | 0.036 | 0.004 | 0.018 | 0.003 |
Pancreas | 0.103 | 0.004 | 0.059 | 0.019 |
Kidney | 0.013 | 0.002 | 0.005 | 0.001 |
Stomach | 0.049 | 0.002 | 0.047 | 0.040 |
Duodenum | 0.013 | 0.003 | 0.008 | 0.003 |
Uro-genital apparatus | 0.137 | 0.044 | 0.048 | 0.049 |
Muscle | 0.006 | 0.000 | 0.003 | 0.002 |